In cardiac myocytes, an enhancement of late sodium current (IN
aL) under pathological conditions is known to cause prolongation of action potential duration (APD). This study investigated the contribution of IN
aL under basal, physiological conditions to the APD. Whole‐cell IN
aL and the APD of ventricular myocytes isolated from healthy adult guinea pigs were measured at 36°C. The IN
aL inhibitor GS967 or TTX was applied to block IN
aL. The amplitude of basal IN
aL and the APD at 50% repolarization in myocytes stimulated at a frequency of 0.17 Hz were ‐0.24 ± 0.02 pA/pF and 229 ± 6 msec, respectively. GS967 (0.01–1 μmol/L) concentration dependently reduced the basal I
NaL by 18 ± 3–82 ± 4%. At the same concentrations, GS967 shortened the APD by 9 ± 2 to 25 ± 1%. Similarly, TTX at 0.1–10 μmol/L decreased the basal I
NaL by 13 ± 1–94 ± 1% and APD by 8 ± 1–31 ± 2%. There was a close correlation (R
2 = 0.958) between the percentage inhibition of IN
aL and the percentage shortening of APD caused by either GS967 or TTX. MTSEA (methanethiosulfonate ethylammonium, 2 mmol/L), a NaV1.5 channel blocker, reduced the I
NaL by 90 ± 5%, suggesting that the NaV1.5 channel isoform is the major contributor to the basal I
NaL. KN‐93 (10 μmol/L) and AIP (2 μmol/L), blockers of CaMKII, moderately reduced the basal I
NaL. Thus, this study provides strong evidence that basal endogenous I
NaL is a significant contributor to the APD of cardiac myocytes. In addition, the basal I
NaL of guinea pig ventricular myocytes is mainly generated from NaV1.5 channel isoform and is regulated by CaMKII.